Key Activities

Panoramic database: 750K+ breast cancer patients; 26K+ ovarian cancer patients; longitudinal EHR data. Key biomarker work: racial/ethnic inequities in biomarker testing for HR+/HER2- mBC (ASCO 2025 abstract). AI-based PD-L1 biomarker data extraction from EHRs. Flatiron-Foundation Medicine Prospective Clinico-Genomic (PCG) study for community oncology biomarker research.

Dates

– Ongoing